Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 110
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
BMC Pharmacol Toxicol ; 22(1): 25, 2021 05 03.
Artigo em Inglês | MEDLINE | ID: mdl-33941274

RESUMO

BACKGROUND: There are no reports on the incidence of chronic mercury poisoning in a large population in China. This study investigated the epidemiology, clinical manifestations, treatment, and follow-up of Chinese patients with chronic mercury poisoning. METHODS: Data for 288 mercury poisoning patients were collected at our hospital from July 2014 to September 2019, including sex, age, admission time, blood mercury content, urine mercury content, creatinine, urinary mercury/creatinine ratio, 24-h urinary protein levels, electromyography (EMG) findings, renal biopsy, and follow-up. Patient characteristics were evaluated by statistical and correlation analyses. RESULTS: First, mercury poisoning in China mainly occurred through occupational exposure and the inappropriate use of mercury-containing cosmetics and Chinese folk remedies (CFRs). Second, the most common symptoms were nervous system (50.3 %), kidney (16.4 %) and breathing (8.0 %). Mercury poisoning-induced Nephrotic syndrome (NS) and peripheral neuropathy are common long-term complications. The complications of occupational and cosmetics-induced mercury poisoning are consistent with international belief. However, the NS caused by CFRs is mainly membranous nephropathy and the probability of peripheral neuropathy caused by CFRs is higher than other pathogens. Third, follow-up data shows that 13 patients with EMG-confirmed neurological injury, 10 showed full recovery after 38.50 ± 8.03 months. Furthermore, among 18 patients with NS, 15 had normal urine protein and serum albumin levels after 22.67 ± 10.26 months. CONCLUSIONS: Regulation of skin-lightening cosmetic products, safety surveillance of CFRs, and prevention and control of occupational exposure must be improved to decrease the incidence of mercury poisoning in China.


Assuntos
Intoxicação por Mercúrio , Doenças Profissionais , Adolescente , Adulto , Idoso , Anti-Inflamatórios/uso terapêutico , Quelantes/uso terapêutico , Criança , Pré-Escolar , China/epidemiologia , Doença Crônica , Cosméticos/toxicidade , Medicamentos de Ervas Chinesas/toxicidade , Feminino , Seguimentos , Humanos , Masculino , Mercúrio/sangue , Mercúrio/urina , Intoxicação por Mercúrio/sangue , Intoxicação por Mercúrio/tratamento farmacológico , Intoxicação por Mercúrio/epidemiologia , Intoxicação por Mercúrio/urina , Pessoa de Meia-Idade , Doenças Profissionais/sangue , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/epidemiologia , Doenças Profissionais/urina , Exposição Ocupacional/efeitos adversos , Prednisona/uso terapêutico , Estudos Retrospectivos , Unitiol/uso terapêutico , Adulto Jovem
2.
Skin Pharmacol Physiol ; 34(3): 135-145, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33789311

RESUMO

BACKGROUND: Oral supplementation with a standardized extract from the bark of the French pine (Pycnogenol®) has been reported to benefit the skin. It might thus represent an easy-to-use strategy to improve the skin health of individuals who are exposed to considerable environmental stress in large urban areas. OBJECTIVE: We investigated if oral intake of Pycnogenol® can benefit the skin of Han Chinese working outdoors in Beijing, China. METHODS: In a monocentre, double-blind, randomized, placebo-controlled, and crossover study, the effects of Pycnogenol® intake (2 × 50 mg/day for a total of 12 weeks) on a variety of skin physiological parameters was studied in Chinese subjects (n = 76), from spring to autumn, who were working outdoors in Beijing, China. RESULTS: During the intervention period, study subjects were constantly exposed to increased levels of particulate matter (PM)2.5 as well as seasonal changes in humidity and temperature. Despite this environmental stress, Pycnogenol® intake prevented (i) a decrease in the skin hydration, (ii) transepidermal water loss (TEWL), and (iii) skin darkening during the dry autumn season. In addition, Pycnogenol® intake improved (iv) viscoelastic skin properties such as gross elasticity and elastic recovery irrespective of the season. These beneficial effects were not observed if the same subjects were supplemented with placebo. CONCLUSION: Oral intake of Pycnogenol® benefits the skin in Han Chinese, who are working outdoors under considerable environmental stress.


Assuntos
Antioxidantes/farmacologia , Flavonoides/farmacologia , Extratos Vegetais/farmacologia , Pele/efeitos dos fármacos , China , Estudos Cross-Over , Método Duplo-Cego , Humanos , Doenças Profissionais/tratamento farmacológico , Material Particulado/análise , Estações do Ano , Pele/metabolismo , Água/metabolismo
3.
Int J Occup Med Environ Health ; 34(1): 111-120, 2021 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-33300502

RESUMO

OBJECTIVES: Evaluating treatment outcomes of local corticosteroid injections for work-related lower back pain (LBP) as the current evidence for the American College of Occupational and Environmental Medicine guidelines is considered insufficient to recommend this practice. MATERIAL AND METHODS: The authors conducted a retrospective study involving the patients who were treated with peri-articular and lower lumbar corticosteroid injections for work-related LBP at their occupational medicine clinic. RESULTS: Sixty-four patients met the inclusion criteria. The average pain level was reduced from M±SD 5.1±2.0 to M±SD 3.1±2.3 after the corticosteroid injection (p < 0.0001). Thirty-five patients (55%) were discharged to regular duty; 23 (36%) were transferred to orthopedics due to persistent pain; and 6 (9%) were lost to follow-up. CONCLUSIONS: Corticosteroid injections for work-related LBP are effective in reducing pain and enhancing discharge to regular duty. Nonetheless, larger prospective trials are needed to validate these findings. Int J Occup Med Environ Health. 2021;34(1):111-20.


Assuntos
Corticosteroides/uso terapêutico , Dor Lombar/tratamento farmacológico , Entorses e Distensões/tratamento farmacológico , Corticosteroides/administração & dosagem , Adulto , Idoso , California , Feminino , Humanos , Injeções Intra-Articulares , Região Lombossacral/lesões , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/tratamento farmacológico , Estudos Retrospectivos , Retorno ao Trabalho/estatística & dados numéricos , Articulação Sacroilíaca , Resultado do Tratamento
4.
Int J Dermatol ; 60(1): 99-106, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33166092

RESUMO

BACKGROUND: Cutaneous sporotrichosis, a subcutaneous mycosis because of Sporothrix schenckii, is sporadic worldwide with local hyperendemic pockets. OBJECTIVES: To study clinico-epidemiological and therapeutic aspects of sporotrichosis in our clinic. METHODS: We retrospectively analyzed medical records of 152 (M:F 52:100) patients with cutaneous sporotrichosis managed during 2010-2019. RESULTS: All patients were involved in agricultural activities, and 63.2% were aged 21-60 years. Women outnumbered men by nearly two times. Fixed and lymphocutaneous sporotrichosis occurred in 54.6% and 43.4% patients, respectively. Only 2% of patients had multifocal sporotrichosis. Only 48% of patients imputed their disease to prior injuries. Extremities, upper in 53.9% and lower in 21% of patients, were mostly involved. Scrotum involvement in one patient was unusual. A mixed inflammatory infiltrate in 38.7%, chronic granuloma formation in 35%, and presence of spores in 48.9% biopsies was noted. S. schenckii grew on Sabouraud's dextrose agar in 40.2% of cases. Treatment with saturated solution of potassium iodide was curative in 76.8% patients, and lesions healed in 2-9 months (average 5.2 months). Metallic taste was experienced by 42.9% of patients. Itraconazole therapy was safe and effective in seven patients, and the response was better when combined with SSKI compared to either drug used alone. CONCLUSION: Cutaneous sporotrichosis mostly affects persons during active years of life. The injuries predisposing to infection are mostly forgotten. Both fixed and lymphocutaneous sporotrichosis involving extremities remain common forms. SSKI alone or in combination with itraconazole is safe and effective treatment. Itraconazole is preferable in patients having preexisting hypothyroidism or intolerance to SSKI.


Assuntos
Agricultura , Antifúngicos/uso terapêutico , Granuloma/microbiologia , Doenças Profissionais/tratamento farmacológico , Iodeto de Potássio/uso terapêutico , Esporotricose/tratamento farmacológico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antifúngicos/efeitos adversos , Criança , Tratamento Farmacológico , Extremidades , Feminino , Humanos , Índia/epidemiologia , Itraconazol/uso terapêutico , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/epidemiologia , Doenças Profissionais/etiologia , Doenças Profissionais/patologia , Iodeto de Potássio/efeitos adversos , Estudos Retrospectivos , Esporos Fúngicos , Esporotricose/epidemiologia , Esporotricose/etiologia , Esporotricose/patologia , Ferimentos e Lesões/complicações , Adulto Jovem
5.
Medicine (Baltimore) ; 98(30): e16466, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31348248

RESUMO

INTRODUCTION: In Korea, low back pain (LBP) which is occupation-related symptom is one of the major health issues owing to rapid industrialization. Even traditional Korean medicine has the long history in pain treatment, there still has been lack of supporting evidence on herbal prescription itself. Sogyeonghwalhyeol-tang, a Korean herbal medicine prescription, has been suggested as a medication for treating chronic LBP as well as work-related pains. OBJECTIVE: This study aims to evaluate the clinical efficacy and safety of herbal medicine, Sogyeonghwalhyeol-tang on work-related chronic LBP patients. METHOD: This trial is designed as a multicenter, randomized, controlled, clinical trial. Seventy-two participants who have chief complaint of LBP in Korean medicine rehabilitation center will be randomly assigned to ether Sogyeonghwalhyeol-tang group or placebo group with a ratio of 1:1. They will receive assigned drugs in 4 weeks and follow-up for 2 weeks. DISCUSSION: The result of this study will provide the valuable information for efficacy and safety of Sogyeonghwalhyeol-tang for patients with work-related chronic LBP.


Assuntos
Dor Lombar/tratamento farmacológico , Medicina Tradicional Coreana/métodos , Doenças Profissionais/tratamento farmacológico , Preparações de Plantas/uso terapêutico , Método Duplo-Cego , Humanos , Medição da Dor , Preparações de Plantas/administração & dosagem , Preparações de Plantas/efeitos adversos , Qualidade de Vida , República da Coreia
6.
J Complement Integr Med ; 16(4)2019 Jun 13.
Artigo em Inglês | MEDLINE | ID: mdl-31199767

RESUMO

Background Aflatoxin B1 (AFB1) is classified as a Group I carcinogen. A Previous study found that oxidative stress from the metabolism of AFB1 induced hepatotoxic effects in wheat miller workers. Zinc and vitamin C may play a significant role in the activation of detoxification and overcoming the oxidative stress of AFB1. Objectives A prospective clinical trial was designed to evaluate the role of zinc and vitamin C oral supplementation on the oxidant-antioxidant status and the hepatotoxic effects of AFB1 in wheat miller workers. Methods Liver enzymes (ALT, AST, ALP, and GGT), P53 protein, malondialdehyde (MDA), glutathione S transferase (GST), Superoxide dismutase (SOD), zinc and vitamin C were estimated in 35 wheat miller workers before and after zinc and vitamin C supplementation for 1 month. Results The results revealed that zinc and vitamin C were significantly increased after the one-month supplementation, while liver enzymes (AST, ALP, and GGT), MDA, and GST of the workers were significantly decreased. SOD and P53 were also decreased but not to a significant level; SOD was decreased in 56% and P53 was decreased in 58% of the total workers. Conclusions Zinc and vitamin C oral supplementation for 1 month had an ameliorative effect on the hepatotoxicity of AFB1 in wheat miller workers, through decreasing MDA, SOD, and GST levels that in turn led to an improvement in their liver enzymes. Further study on a larger scale is needed to confirm these results.


Assuntos
Aflatoxina B1/toxicidade , Antioxidantes/uso terapêutico , Ácido Ascórbico/uso terapêutico , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Doenças Profissionais/tratamento farmacológico , Zinco/uso terapêutico , Adulto , Aflatoxina B1/metabolismo , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Suplementos Nutricionais , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/etiologia , Exposição Ocupacional/efeitos adversos , Estresse Oxidativo/efeitos dos fármacos , Material Particulado/toxicidade , Estudos Prospectivos , Triticum/microbiologia
7.
BMJ Case Rep ; 12(5)2019 May 14.
Artigo em Inglês | MEDLINE | ID: mdl-31092494

RESUMO

Erythema multiforme is a skin disorder characterised by target epithelial eruption, which is mainly caused by infection or drugs. In this case, we report an erythema multiforme like reaction caused by contact dermatitis against wood, especially santos rosewood. During the hospitalisation, we performed a patch test with lumber used in the patient's workplace, and recognised a positive response to multiple woods and a simultaneous recurring eruption (flare up) outside of the test site. The findings from this case of contact dermatitis caused by frequently used industrial wood type is important for the management of occupational environments. A review of the literature on erythema multiforme like reaction due to contact dermatitis, including past case reports, has also been provided.


Assuntos
Eritema Multiforme/etiologia , Doenças Profissionais/etiologia , Madeira/efeitos adversos , Administração Cutânea , Adulto , Clobetasol/administração & dosagem , Dermatite Alérgica de Contato , Eritema Multiforme/diagnóstico , Eritema Multiforme/tratamento farmacológico , Fabaceae/efeitos adversos , Humanos , Masculino , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Testes do Emplastro , Taxaceae/efeitos adversos
8.
Med J Aust ; 207(10): 449-452, 2017 Nov 20.
Artigo em Inglês | MEDLINE | ID: mdl-29129162

RESUMO

The incidence of malignant mesothelioma in Australia is among the highest in the world as a result of widespread use of asbestos by industry and in construction throughout the 20th century. The risk of developing malignant mesothelioma after asbestos exposure is dose-related; a transient, low dose exposure confers a correspondingly very low risk of disease. Malignant mesothelioma is a heterogeneous disease, partly explaining the limited role of biomarkers in screening and diagnosis. The prognosis remains poor, and early advice on medico-legal compensation and a collaborative team approach to managing malignant mesothelioma are both essential. Chemotherapy can have a modest treatment effect in some people. New therapies, such as immunotherapy, do not yet have a defined role in the treatment of malignant mesothelioma. As treatment options for malignant mesothelioma are limited and no cure is available, there is no established role for early detection or screening of at risk populations. A multidisciplinary approach to caring for patients with malignant mesothelioma and their carers is vital.


Assuntos
Amianto , Mesotelioma/epidemiologia , Doenças Profissionais/epidemiologia , Neoplasias Pleurais/epidemiologia , Antineoplásicos/uso terapêutico , Austrália/epidemiologia , Compensação e Reparação , Humanos , Incidência , Mesotelioma/tratamento farmacológico , Doenças Profissionais/tratamento farmacológico , Exposição Ocupacional/estatística & dados numéricos , Neoplasias Pleurais/tratamento farmacológico , Prognóstico
9.
Vestn Otorinolaringol ; 82(3): 48-53, 2017.
Artigo em Russo | MEDLINE | ID: mdl-28631682

RESUMO

The objective of the present study was to evaluate the effectiveness of the application of homeovox for the combined treatment of small vocal cord nodules and acute laryngitis in the professional voice users. A total of 40 subjects presenting with dysphonia were examined after they were divided into two study groups and two groups of comparison depending on the nosological form of the pathological condition. The subjects comprising the study groups were given traditional therapy in the combination with the intake of homeovox whereas the patients included in the two groups of comparison received the traditional treatment alone. The outcome of the treatment was evaluated on days 1, 5, and 10 after the initiation of therapy based on the analysis of the changes in the videoendostroboscopic picture of the larynx and the acoustic characteristics obtained by the computer-assisted analysis of the voice. The analysis of the results of the combined treatment has demonstrated the statistically significant differences in some acoustic parameters of the voice between the subjects with small vocal cord nodules and acute laryngitis belonging to the study groups and the groups of comparison. It is concluded that the introduction of homeovox in the combined treatment of the patients presenting with the small nodules in the vocal cords and acute catarrhal laryngitis accelerates the recovery of the acoustic characteristics of the voice within various periods after the onset of the treatment in comparison with the patients treated with the use of traditional therapy alone.


Assuntos
Disfonia , Materia Medica/administração & dosagem , Doenças Profissionais , Qualidade da Voz/efeitos dos fármacos , Adulto , Anti-Inflamatórios/administração & dosagem , Monitoramento de Medicamentos , Quimioterapia Combinada/métodos , Disfonia/diagnóstico , Disfonia/tratamento farmacológico , Disfonia/etiologia , Disfonia/fisiopatologia , Expectorantes/administração & dosagem , Feminino , Humanos , Laringoscopia/métodos , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/etiologia , Doenças Profissionais/fisiopatologia , Resultado do Tratamento
10.
Food Chem Toxicol ; 106(Pt B): 616-623, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28011361

RESUMO

The CaNa2EDTA chelation therapy is often practiced with antioxidant supplementation. Dry olive leaf extract (DOLE) is natural product with antioxidant and DNA protective properties. The effects of DOLE on the levels of DNA damage were investigated ex vivo in peripheral blood lymphocytes (PBLs) of 19 workers occupationally exposed to lead (Pb), before and after CaNa2EDTA chelation therapy. DOLE demonstrated pronounced radical scavenging activity in concentrations ≥1 mg/mL, and showed no genotoxicity per se, in concentrations 0.125-1 mg/mL. The level of DNA damage in PBLs of workers before chelation therapy was elevated (24.21 ± 14.26) compared to controls (6.0 ± 3.37). The incubation of PBLs before chelation therapy with selected concentration of DOLE lead to a severe increase of DNA damage (64.03 ± 20.96), exhibiting prooxidant rather than antioxidant effect. After the five-day CaNa2EDTA chelation regimen, DNA damage in PBLs of workers decreased (8.26 ± 4.62) significantly compared to baseline. Treatment of PBLs with DOLE after chelation, again produced high level of damage (41.82 ± 23.17) and the acute prooxidant effects of DOLE remained, but, DNA damage was less severe than before chelation. The DOLE exhibits prooxidant effect in presence of Pb in lymphocytes of exposed workers, and its effect is less pronounced following the removal of Pb after standard chelation therapy.


Assuntos
Quelantes/administração & dosagem , Terapia por Quelação , Dano ao DNA/efeitos dos fármacos , Intoxicação por Chumbo/tratamento farmacológico , Chumbo/toxicidade , Linfócitos/efeitos dos fármacos , Doenças Profissionais/tratamento farmacológico , Olea/química , Extratos Vegetais/administração & dosagem , Adulto , Antioxidantes/administração & dosagem , Feminino , Humanos , Intoxicação por Chumbo/sangue , Intoxicação por Chumbo/genética , Intoxicação por Chumbo/metabolismo , Linfócitos/metabolismo , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/sangue , Doenças Profissionais/genética , Doenças Profissionais/metabolismo , Exposição Ocupacional/efeitos adversos , Estresse Oxidativo/efeitos dos fármacos , Folhas de Planta/química
11.
Med Tr Prom Ekol ; (4): 36-40, 2016.
Artigo em Russo | MEDLINE | ID: mdl-27396151

RESUMO

Complex treatment using naphthalane applications with nonselective chromotherapy covered 64 engine operators of locomotive crews, aged 40-69 years, having 1-3 stage knee osteoarthrosis. Findings are that optimized treatment schedules effectively reduce intensity of pain, improve functional state of the joints involved, increase life quality of the patients, have no side effects. Comparative analysis of the treatment results showed that efficiency of combined naphthalane and nonselective chromotherapy exceeds isolated naphthalane effects.


Assuntos
Cromoterapia/métodos , Naftalenos/farmacologia , Doenças Profissionais/terapia , Osteoartrite/terapia , Ferrovias , Adulto , Idoso , Humanos , Masculino , Pessoa de Meia-Idade , Naftalenos/administração & dosagem , Doenças Profissionais/tratamento farmacológico , Osteoartrite/tratamento farmacológico
12.
J Clin Gastroenterol ; 50(9): 769-71, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-26627699

RESUMO

Inorganic lead intoxication has emerged as an important and challenging clinical problem owing to increased awareness of lead and enhanced surveillance of exposed individuals. However, recognition may not be very difficult when there is an obvious history of exposure. Our interest began a few years ago when we could trace an outbreak, following a patient who was admitted with colickly abdominal pain, convulsions, and coma. After that, 16 more cases were identified and characterized. All patients recovered completely after adequate chelation therapy. Although the clinical picture of lead intoxication is pleomorphic, the increased awareness of gastroenterologists in this subject may possibly bring chronically complaining difficult patients to an earlier, unexpected, and fairly treatable disease.


Assuntos
Surtos de Doenças , Intoxicação por Chumbo/epidemiologia , Abdome Agudo/etiologia , Adolescente , Adulto , Terapia por Quelação , Criança , Exposição Ambiental , Feminino , Humanos , Intoxicação por Chumbo/complicações , Intoxicação por Chumbo/diagnóstico , Intoxicação por Chumbo/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/complicações , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/epidemiologia , Portugal/epidemiologia , Adulto Jovem
13.
Actas Dermosifiliogr ; 106(7): 533-44, 2015 Sep.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-26005193

RESUMO

Management of hand eczema is complex because of the broad range of different pathogeneses, courses, and prognoses. Furthermore, the efficacy of most available treatments is not well established and the more severe forms can have a major impact on the patient's quality of life. Patient education, preventive measures, and the use of emollients are the mainstays in the management of hand eczema. High-potency topical corticosteroids are the treatment of choice, with calcineurin inhibitors used for maintenance. Phototherapy or systemic treatments are indicated in patients who do not respond to topical treatments. Switching from topical treatments should not be delayed to avoid sensitizations, time off work, and a negative impact on quality of life. Alitretinoin is the only oral treatment approved for use in chronic hand eczema.


Assuntos
Fármacos Dermatológicos/uso terapêutico , Eczema/tratamento farmacológico , Dermatoses da Mão/tratamento farmacológico , Corticosteroides/uso terapêutico , Alitretinoína , Inibidores de Calcineurina/uso terapêutico , Doença Crônica , Terapia Combinada , Dermatite de Contato/tratamento farmacológico , Dermatite de Contato/prevenção & controle , Dermatite de Contato/terapia , Gerenciamento Clínico , Eczema/prevenção & controle , Eczema/terapia , Emolientes/uso terapêutico , Luvas Protetoras , Dermatoses da Mão/prevenção & controle , Dermatoses da Mão/terapia , Humanos , Imunossupressores/uso terapêutico , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/prevenção & controle , Doenças Profissionais/terapia , Fototerapia , Guias de Prática Clínica como Assunto , Qualidade de Vida , Tretinoína/uso terapêutico
14.
Med Pr ; 65(3): 309-16, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25230559

RESUMO

BACKGROUND: Oxidative stress is involved in lead toxicity. This suggests that some antioxidants may play a role in the treatment of lead poisoning. In the light of this, the aim of the study was to determine whether beta-carotene administration reduces oxidative stress and homocysteine level in workers chronically exposed to lead. MATERIAL AND METHODS: The exposed population included healthy male workers exposed to lead who were randomly divided into 2 groups (mean blood lead level ca. 44 microg/dl). Workers in the 1st group (N = 49, reference group) had no antioxidants, drugs, vitamins or dietary supplements administered, while workers in the 2nd group (N = 33) had beta-carotene administered in a dose of 10 mg per day for 12 weeks. Biochemical analysis included markers of lead-exposure and the level of malondialdehyde (MDA), an oxidative stress biomarker. We also measured the level of homocysteine (Hcy) and thiol groups as well as the activity of superoxide dismutase (SOD) and its isoenzyme EC-SOD in serum. RESULTS: After supplementation, the level of MDA significantly decreased, compared to baseline, by 16%, and to the reference group. When compared to the reference group, Hcy level was also significantly decreased. However, the level of thiol groups was significantly higher after supplementation with beta-carotene compared to the reference group. Analogically, the activity of SOD and EC-SOD was significantly higher compared to the baseline and to the reference group. CONCLUSIONS: Despite some controversies over antioxidant properties of beta-carotene, our results indicate that its antioxidant action could provide some beneficial effects in lead poisoning independent of chelation.


Assuntos
Homocisteína/sangue , Intoxicação por Chumbo/sangue , Intoxicação por Chumbo/tratamento farmacológico , Doenças Profissionais/sangue , Doenças Profissionais/tratamento farmacológico , Estresse Oxidativo/efeitos dos fármacos , beta Caroteno/uso terapêutico , Antioxidantes/uso terapêutico , Humanos , Masculino , Malondialdeído/sangue , Pessoa de Meia-Idade , Polônia , Compostos de Sulfidrila/sangue , Superóxido Dismutase/sangue
15.
J Opioid Manag ; 10(4): 277-83, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25162607

RESUMO

Buprenorphine is approved by the Food and Drug Administration for the treatment of chronic pain in low-dose transdermal patch formulations and for the treatment of addiction in high-dose sublingual tablets and films. Clinicians often prescribe these high-dose preparations "off label" for pain management. In the workers' compensation setting, it is particularly important to consider factors such as a) if the injured person has, and is being treated for co-occurring addiction as well as pain; b) if alternative therapies, including opioid withdrawal, were considered prior to initiating buprenorphine treatment; and c) the anticipated duration of treatment. This article reviews buprenorphine's approved indications, formulations, pharmacology, clinical efficacy, and special considerations in the workers' compensation setting.


Assuntos
Analgésicos Opioides/uso terapêutico , Buprenorfina/uso terapêutico , Doenças Profissionais/tratamento farmacológico , Saúde Ocupacional , Indenização aos Trabalhadores , Administração Sublingual , Analgésicos Opioides/administração & dosagem , Analgésicos Opioides/efeitos adversos , Analgésicos Opioides/química , Buprenorfina/administração & dosagem , Buprenorfina/efeitos adversos , Buprenorfina/química , Esquema de Medicação , Aprovação de Drogas , Humanos , Doenças Profissionais/diagnóstico , Doenças Profissionais/etiologia , Uso Off-Label , Transtornos Relacionados ao Uso de Opioides/etiologia , Transtornos Relacionados ao Uso de Opioides/prevenção & controle , Seleção de Pacientes , Medição de Risco , Fatores de Risco , Comprimidos
16.
Toxicol Appl Pharmacol ; 280(1): 36-41, 2014 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-25038314

RESUMO

The aim of this study was to determine whether beta-carotene administration reduces oxidative stress and influences antioxidant, mainly glutathione-related, defense systems in workers chronically exposed to lead. The population consisted of two randomly divided groups of healthy male volunteers exposed to lead. Workers in the first group (reference group) were not administered any antioxidants, while workers in the second group (CAR group) were treated orally with 10mg of beta-carotene once a day for 12weeks. Biochemical analysis included measuring markers of lead-exposure and oxidative stress in addition to the levels and activities of selected antioxidants. After treatment, levels of malondialdehyde, lipid hydroperoxides and lipofuscin significantly decreased compared with the reference group. However, the level of glutathione significantly increased compared with the baseline. Treatment with beta-carotene also resulted in significantly decreased glutathione peroxidase activity compared with the reference group, while the activities of other glutathione-related enzymes and of superoxide dismutase were not significantly changed. However, the activities of glucose-6-phosphate dehydrogenase and catalase, as well as the level of alpha-tocopherol, were significantly higher after treatment compared with the baseline. Despite controversy over the antioxidant properties of beta-carotene in vivo, our findings showed reduced oxidative stress after beta-carotene supplementation in chronic lead poisoning.


Assuntos
Antioxidantes/metabolismo , Glutationa/metabolismo , Intoxicação por Chumbo/tratamento farmacológico , Doenças Profissionais/tratamento farmacológico , Estresse Oxidativo/fisiologia , beta Caroteno/uso terapêutico , Adulto , Humanos , Intoxicação por Chumbo/sangue , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/sangue , Estresse Oxidativo/efeitos dos fármacos , Adulto Jovem , beta Caroteno/farmacologia
17.
G Ital Med Lav Ergon ; 36(4): 234-43, 2014.
Artigo em Espanhol | MEDLINE | ID: mdl-25558716

RESUMO

Baker's asthma, though having been recognized and studied since long time, still stays one of the most common causes of occupational asthma. Moreover, our understanding of the causative agents, the pathophysiological mnechanisms, the usefulness of medical surveillance, the proper treatment and prevention of the disease is still scanty. This is due to either to its complex pathogenesis or to possible confoundings, besides the still inadequate quality and standardization of the tools available as far as the allergologic diagnosis is concerned. Proper medical surveillance, validated causal therapies, efficient primary prevention are still uncertain. Change of employment or relocation is often impossible, particularly among artisan workers. Various evidences have been critically revised and summarized.


Assuntos
Asma/etiologia , Poeira , Farinha/efeitos adversos , Doenças Profissionais/etiologia , Poluição do Ar em Ambientes Fechados , Antialérgicos/uso terapêutico , Antiasmáticos/uso terapêutico , Anticorpos Anti-Idiotípicos/uso terapêutico , Anticorpos Monoclonais Humanizados/uso terapêutico , Asma/diagnóstico , Asma/tratamento farmacológico , Asma/epidemiologia , Asma/prevenção & controle , Grão Comestível/efeitos adversos , Fabaceae/efeitos adversos , Aditivos Alimentares/efeitos adversos , Hipersensibilidade Alimentar/complicações , Hipersensibilidade Alimentar/tratamento farmacológico , Microbiologia de Alimentos , Frutas/efeitos adversos , Guias como Assunto , Humanos , Imunoglobulina E/imunologia , Itália , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/epidemiologia , Doenças Profissionais/prevenção & controle , Omalizumab
18.
Int J Occup Med Environ Health ; 26(3): 401-12, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24018996

RESUMO

OBJECTIVE: The aim of this study was to review recent medical findings related to burnout, its diagnosis, treatment, characteristic pathophysiological features, and preventive measures. MATERIALS AND METHODS: A systematic review of the scientific literature in PubMed/Medline was performed. The most recent and important findings were reported. RESULTS: Burnout was found to be a risk factor for myocardial infarction and coronary heart disease. It was also related to reduced fibrinolytic capacity, decreased capacity to cope with stress and hypothalamic-pituitary-adrenal (HPA) axis hypoactivity. Severe burnout symptoms are associated with a lower level or smaller increase of the cortisol awakening response (CAR), higher dehydroepiandrosterone-sulphate (DHEAS) levels, lower cortisol/DHEAS ratios and stronger suppression as measured by the dexamethasone suppression test (DST). More and more literature works suggest that the evaluation of the HPA axis should be brought to the attention of primary care physicians. There is no universal agreement on specific treatment and diagnostic measures to evaluate the wide range of HPA axis disorders. The cost-effective evaluation of adrenal hormones via saliva samples by a primary care physician may significantly alter the course of therapy in numerous chronic disease patients. Psychiatric disorders may have similar symptoms, but they have distinctive hormonal profiles. Having burnout recognized as a medical condition would help in differentiating burnout from similar clinical syndromes, such as depression or anxiety, and provide appropriate treatment to burnout patients. Proper treatment is essential for a fast and full recovery. CONCLUSION: Chronic stress-related disorders often fall outside the category of a "true" disease and are often treated as depression or not treated at all. The evaluation of adrenal hormones via saliva samples helps to predict burnout. Burnout screening techniques, dietary and nutritional guidelines and lifestyle changes for supporting the HPA function need to be developed. The presented material includes hormonal, dietary, and pharmaceutical perspectives.


Assuntos
Esgotamento Profissional/diagnóstico , Esgotamento Profissional/tratamento farmacológico , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Ansiolíticos/uso terapêutico , Antidepressivos/uso terapêutico , Esgotamento Profissional/metabolismo , Esgotamento Profissional/prevenção & controle , Suplementos Nutricionais , Humanos , Hipnóticos e Sedativos/uso terapêutico , Sistema Hipotálamo-Hipofisário/metabolismo , Doenças Profissionais/epidemiologia , Doenças Profissionais/prevenção & controle , Sistema Hipófise-Suprarrenal/metabolismo , Inquéritos e Questionários
19.
Med Lav ; 104(6): 428-33, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24640829

RESUMO

BACKGROUND: In most industrialized countries, occupational lead poisoning has become increasingly rare, however this metal remains a serious health hazard in the rest of the world. REPORT OF CASES: We observedfour male patients (aged 35 / 54 years) who had suffered recurrent abdominal pain due to recent lead exposure (for 7 to 13 months) in two Chinese battery recycling plants. On their return to Italy, three of them presented normocytic, normochromic anaemia. The diagnosis was confirmed by high lead levels in the blood and urine, decreased erythrocyte delta-aminolevulinic acid dehydratase (ALA-D), raised erythrocyte zinc protoporphyrin (ZP), and elevated urinary excretion of b-aminolevulinic acid (ALA-U) and porphyrins. Chelation with EDTA resulted in increased urinary lead excretion, improvement of the clinical picture, decreased ZP, and progressive normalization of the other lead biomarkers (Pb-B, ALA-D, ALA-U, urinary porphyrins). CONCLUSIONS: Temporary work in developing countries may result in imported lead poisoning. Differential diagnosis of this unusual condition requires careful medical history collection and specific toxicological analysis. Preventive measures for workers going abroad are needed.


Assuntos
Intoxicação por Chumbo/diagnóstico , Intoxicação por Chumbo/prevenção & controle , Doenças Profissionais/diagnóstico , Doenças Profissionais/prevenção & controle , Exposição Ocupacional/prevenção & controle , Dor Abdominal/induzido quimicamente , Adulto , Ácido Aminolevulínico/sangue , Ácido Aminolevulínico/urina , Anemia/induzido quimicamente , Biomarcadores/sangue , Biomarcadores/urina , Quelantes/uso terapêutico , Terapia por Quelação/métodos , China , Países em Desenvolvimento , Diagnóstico Diferencial , Ácido Edético/uso terapêutico , Humanos , Itália , Chumbo/sangue , Chumbo/urina , Intoxicação por Chumbo/sangue , Intoxicação por Chumbo/tratamento farmacológico , Intoxicação por Chumbo/urina , Masculino , Anamnese , Metalurgia , Pessoa de Meia-Idade , Doenças Profissionais/sangue , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/urina , Exposição Ocupacional/efeitos adversos , Protoporfirinas/sangue , Protoporfirinas/urina , Reciclagem , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA